CALL US:022-2204 0015 / 16 / 17   isa@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Shardul Nautiyal, Mumbai November 15 , 2017
The Andhra Pradesh MedTech Zone (AMTZ) - India’s first government funded medical devices manufacturing park, will soon set up eight medical device testing labs under one roof. This will provide medical device testing facilities to around 180 companies at AMTZ in the coming eight months time.

“Currently 38 companies have set up 53 units in AMTZ which has a total capacity of 180 companies. These companies can set up a total 240 units in the coming time. A comprehensive facility to test all medical devices under one roof will also be provided to the companies in AMTZ in coming eight months time,” says a senior official associated with the development.

AMTZ has also inked formal agreements with the various scientific facilities which will be housed within the country’s first Medical Technology Manufacturing Park spread over 270 acre.

Scientific facilities include Centre for Electro-Magnetic Interference/ Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for Biomaterials Testing, Centre for X-ray and CT Scan Tube Manufacturing, Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling, Centre for Gamma Irradiation and AMTZ Central Warehouse.

As on date, 23 devices have been notified by the Central government. The notified devices are required to be registered prior to sale, whereas those not notified can be sold without registration.

The AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Kalam Institute of Health Technology (KIHT), India’s first institute dedicated to medical technology located at AMTZ, Visakhapatnam which  recently held its 1st Governing Body meeting in Delhi, is also working towards building a robust system for innovation in the medical devices sector in the country. It recently received 100 per cent financial support from the Department of Biotechnology (DBT).

The Governing body led by Prof. Vijay Raghavan hailed the uniqueness of the KIHT model in bringing academia and industry together. The Governing Body members applauded the conceptualization and idea of KIHT to support Government for focussed R&D policy in the medical devices sector through its Cell for Research and Development (CRD).

KIHT’s Cell of Technology Transfer (CTT) will facilitate academia with rapid technology transfer and product certifications, while the Cell for Innovation and Market Access (CIM) will enable industry with technology access and drive innovation of next generation of medtech products. The Cell for Market Intelligence and Trade (CMT) will work with respective department/ministry towards elimination of trade barriers. CMT will also undertake research and analysis of relevant data to help in developing long term strategies for the medical device industry.

KIHT is working towards hosting a first of its kind congregation of innovators, investors and manufacturers for technology transfer from academia to industry for commercialization. KIHT’s proposition is further strengthened through its partnership with Association of Indian Medical Device Manufacturers (AIMED) which brings access to technical bandwidth from the industry and opportunities for deeper collaboration with the medical device industry.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
         
Website (required)
   
CommenT
 
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
Globalisation has brought many changes in lifestyles of human beings. Although we have been living a luxurious life, it ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2013 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Internet Explorer(9.0) or Firefox(26.0)